GO
Loading...

Eli Lilly and Co

More

  • Final Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 7:08 PM ET

    Baxter International Inc. rose $1.54 or 2.2 percent, to $72.27. Bristol-Myers Squibb Co. rose $1.50 or 2.6 percent, to $59.19. Hospira rose $1.43 or 2.4 percent, to $60.25.

  • Midday Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 1:17 PM ET

    Baxter International Inc. rose$. 93 or 1.3 percent, to $71.66. Bristol-Myers Squibb Co. rose$. 65 or 1.1 percent, to $58.34. Hospira rose $1.11 or 1.9 percent, to $59.93.

  • Early Glance: Pharmaceuticals companies Wednesday, 17 Dec 2014 | 10:16 AM ET

    Baxter International Inc. rose$. 83 or 1.2 percent, to $71.56. Bristol-Myers Squibb Co. rose$. 24 or. 4 percent, to $57.93. Eli Lilly& Co. rose$. 24 or. 3 percent, to $69.50.

  • Final Glance: Pharmaceuticals companies Tuesday, 16 Dec 2014 | 6:41 PM ET

    Baxter International Inc. fell$. 37 or. 5 percent, to $70.73. Bristol-Myers Squibb Co. fell$. 86 or 1.5 percent, to $57.69. Hospira fell $1.52 or 2.5 percent, to $58.82.

  • Midday Glance: Pharmaceuticals companies Tuesday, 16 Dec 2014 | 1:20 PM ET

    Baxter International Inc. rose$. 36 or. 5 percent, to $71.46. Bristol-Myers Squibb Co. fell$. 28 or. 5 percent, to $58.27. Hospira fell$. 57 or. 9 percent, to $59.77.

  • Eli Lilly bumps up dividend for first time since 2009 Tuesday, 16 Dec 2014 | 10:44 AM ET

    INDIANAPOLIS— Shares of Eli Lilly outpaced broader trading indexes Tuesday morning, a day after the drugmaker announced its first dividend increase in more than five years. That will raise the quarterly payout to 50 cents per share, or $2 annually. Eli Lilly and Co. shares climbed about 1 percent, or 71 cents, to $70.38 Tuesday, while the Standard& Poor's 500 index...

  • Early Glance: Pharmaceuticals companies Tuesday, 16 Dec 2014 | 10:20 AM ET

    Baxter International Inc. fell$. 04 or. 1 percent, to $71.06. Bristol-Myers Squibb Co. fell$. 63 or 1.1 percent, to $57.92. Hospira fell$. 37 or. 6 percent, to $59.97.

  • Final Glance: Pharmaceuticals companies Monday, 15 Dec 2014 | 6:08 PM ET

    Baxter International Inc. fell$. 67 or. 9 percent, to $71.10. Bristol-Myers Squibb Co. fell$. 20 or. 3 percent, to $58.55. Hospira rose$. 01 or percent, to $60.34.

  • Early Glance: Pharmaceuticals companies Monday, 15 Dec 2014 | 12:00 PM ET

    Baxter International Inc. rose$. 15 or. 2 percent, to $71.92. Bristol-Myers Squibb Co. fell$. 15 or. 3 percent, to $58.60. Hospira rose $1.01 or 1.7 percent, to $61.34.

  • Final Glance: Pharmaceuticals companies Friday, 12 Dec 2014 | 6:03 PM ET

    Baxter International Inc. fell $1.34 or 1.8 percent, to $71.77. Bristol-Myers Squibb Co. fell$. 93 or 1.6 percent, to $58.75. Hospira fell $1.75 or 2.8 percent, to $60.33.

  • Midday Glance: Pharmaceuticals companies Friday, 12 Dec 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 96 or 1.3 percent, to $72.15. Bristol-Myers Squibb Co. fell$. 44 or. 7 percent, to $59.24. Hospira fell$. 67 or 1.1 percent, to $61.41.

  • Early Glance: Pharmaceuticals companies Friday, 12 Dec 2014 | 10:31 AM ET

    Baxter International Inc. fell$. 57 or. 8 percent, to $72.54. Bristol-Myers Squibb Co. rose$. 17 or. 3 percent, to $59.85. Hospira fell$. 11 or. 2 percent, to $61.97.

  • ZURICH, Dec 12- Novartis said on Friday its experimental psoriasis drug Cosentyx was better at clearing the rough skin patches associated with the disease than Johnson& Johnson's Stelara. The data follows results last year showing Cosentyx, also known as secukinumab, was superior to Amgen's Embrel in a head-to-head study. Other drugmakers working on new...

  • Final Glance: Pharmaceuticals companies Thursday, 11 Dec 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 35 or. 5 percent, to $73.11. Bristol-Myers Squibb Co. rose$. 40 or. 7 percent, to $59.68. Hospira rose $2.69 or 4.5 percent, to $62.08.

  • Midday Glance: Pharmaceuticals companies Thursday, 11 Dec 2014 | 1:19 PM ET

    Baxter International Inc. rose$. 48 or. 7 percent, to $73.24. Bristol-Myers Squibb Co. rose$. 93 or 1.6 percent, to $60.21. Hospira rose $3.10 or 5.2 percent, to $62.49.

  • Early Glance: Pharmaceuticals companies Thursday, 11 Dec 2014 | 11:28 AM ET

    Baxter International Inc. rose$. 59 or. 8 percent, to $73.35. Bristol-Myers Squibb Co. rose$. 71 or 1.2 percent, to $59.99. Hospira rose $2.35 or 4.0 percent, to $61.74.

  • Final Glance: Pharmaceuticals companies Wednesday, 10 Dec 2014 | 6:09 PM ET

    Baxter International Inc. fell $1.03 or 1.4 percent, to $72.76. Bristol-Myers Squibb Co. fell$. 69 or 1.2 percent, to $59.28. Hospira fell$. 97 or 1.6 percent, to $59.39.

  • Midday Glance: Pharmaceuticals companies Wednesday, 10 Dec 2014 | 1:18 PM ET

    Baxter International Inc. fell$. 39 or. 5 percent, to $73.40. Bristol-Myers Squibb Co. rose$. 06 or. 1 percent, to $60.03. Hospira fell$. 11 or. 2 percent, to $60.25.

  • Early Glance: Pharmaceuticals companies Wednesday, 10 Dec 2014 | 10:41 AM ET

    Baxter International Inc. fell$. 08 or. 1 percent, to $73.71. Hospira fell$. 56 or. 9 percent, to $59.80. Eli Lilly& Co. fell$. 56 or. 8 percent, to $71.65.

  • LONDON, Dec 10- Drugmakers are finally getting more bang for their scientific buck, with the rate of return on pharmaceutical research and development increasing for the first time since 2010.. So far this year the U.S. Food and Drug Administration, which acts as gatekeeper to the world's biggest market, has approved 35 new products, up from 27 in the whole of 2013...